Clinical characteristics and prognostic analysis of CDKN2A/2B gene in pediatric acute lymphoblastic leukemia: a retrospective case-control study

Clinical characteristics and prognostic analysis of CDKN2A/2B gene in pediatric acute lymphoblastic leukemia: a retrospective case-control study

In this retrospective case-control study involving 424 pediatric patients diagnosed with Pediatric Acute Lymphoblastic Leukemia (ALL), the investigation focused on analyzing the clinical characteristics and prognosis associated with the Cyclin-dependent kinase inhibitor 2A/2B (CDKN2A/2B) gene. Treat...

Full description

Saved in:

Bibliographic Details
Main Authors:	Shi-Mei Huang, Hui-Qin Chen, Li-Ting Liu, Ya-Ting Zhang, Jian Wang, Dun-Hua Zhou, Jian-Pei Fang, Lu-Hong Xu
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2025-12-01
Series:	Hematology
Subjects:	Pediatric ALL CDKN2A/2B gene deletion clinical characteristics prognosis analysis
Online Access:	https://www.tandfonline.com/doi/10.1080/16078454.2024.2439606
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

A comprehensive consolidation of data on the connection between CDKN2A polymorphisms and the susceptibility to childhood acute lymphoblastic leukemia
by: Maryam Aghasipour, et al.
Published: (2024-12-01)

CDKN2A/p16INK4a DELETION IS NOT A POOR PROGNOSTIC FACTOR IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS TREATED ACCORDING TO PROTOCOL RALL-2009
by: I. S. Piskunova, et al.
Published: (2017-10-01)

Assessment of CDKN2A homozygous and heterozygous deletions in gliomas across multiple detection platforms
by: Hainan Li, et al.
Published: (2025-06-01)

Prevalence and prognostic impact of BRAF V600E mutation and CDKN2A deletion in pediatric high-grade glioma
by: Soha Karim, et al.
Published: (2025-08-01)

Frequency and Prognostic Impact of CDKN2A/B Alteration in Oligodendrogliomas: Systematic Review and Meta-analysis
by: Satoshi NAKASU, et al.
Published: (2024-12-01)

Case report: The smallest 9p21.3 microdeletion involving CDKN2A but not CDKN2B causes multiple plexiform neurofibromas
by: Yuanyuan Zhang, et al.
Published: (2025-02-01)

<i>CDKN2A</i> Homozygous Deletion Is a Stronger Predictor of Outcome than <i>IDH1/2</i>-Mutation in CNS WHO Grade 4 Gliomas
by: Sang Hyuk Lee, et al.
Published: (2024-10-01)

Deoxyribonucleic acid methylation in the enhancer region of the CDKN2A/2B and CDKN2B-AS1 genes in blood vessels and cells in patients with carotid atherosclerosis
by: Yu. A. Koroleva, et al.
Published: (2020-11-01)

Challenging CDKN2A assessment in BRAF-altered gliomas: lessons from a pleomorphic xanthoastrocytoma-enriched cohort
by: Thibaut Wolf, et al.
Published: (2025-08-01)

Association of CDKN2A/B deletions with survival of patients with diffuse large B-cell lymphoma
by: M. V. Sarpova, et al.
Published: (2024-01-01)

CDKN2A Mutation: A Patient’s and Physician’s Experience
by: Yaelle Shaked, et al.
Published: (2025-02-01)

A systematic literature review of MTAP deletions in solid and hematologic Cancers
by: Mary C. Clouser, et al.
Published: (2025-01-01)

IKZF1 DELETIONS ARE INDEPENDENT PROGNOSTIC FACTOR IN PEDIATRIC B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA
by: G. A. Tsaur, et al.
Published: (2017-01-01)

Combination therapy of adagrasib and abemaciclib in non-small cell lung cancer brain metastasis models genomically characterized by KRAS-G12C and homozygous loss of CDKN2A
by: Christian Migliarese, et al.
Published: (2025-05-01)

Effect of the Ethanolic Extract of Eryngium billardieri on the Viability of the Triple-Negative Breast Cancer Cell Line (MDA-MB-231) and CDKN2A, MDM2, and HER2 Expression
by: Azadeh Hekmat, et al.
Published: (2024-12-01)

A case of hereditary CDKN2A p14ARF melanoma and dysplastic nevi
by: Jeremy K. Bray, MD, et al.
Published: (2025-07-01)

Network pharmacological approach combined with weighted gene co-expression network analysis identifies CDKN2A as the keg target of Changweiqing against colorectal cancer
by: Ma Zushuai, et al.
Published: (2025-03-01)

The Potential Association of CDKN2A and Ki-67 Proteins in View of the Selected Characteristics of Patients with Head and Neck Squamous Cell Carcinoma
by: Dariusz Nałęcz, et al.
Published: (2024-11-01)

Blinatumomab in pediatric B-acute lymphoblastic leukemia
by: Yifang Cheng, et al.
Published: (2025-07-01)

CDKN2AIP-induced cell senescence and apoptosis of testicular seminoma are associated with CARM1 and eIF4β
by: Cao Yuming, et al.
Published: (2022-05-01)

Psychological Distress and Quality of Life in Families With a Germline CDKN2A Pathogenic Variant
by: A. M. Onnekink, et al.
Published: (2025-02-01)

Expression of lncRNA CDKN2BAS in oral squamous cell carcinoma and its significance on cell proliferation and invasion
by: JIANG Shengjun, et al.
Published: (2023-08-01)

Construction of a five-gene-based prognostic model for relapsed/refractory acute lymphoblastic leukemia
by: Bi Zhou, et al.
Published: (2024-12-01)

Transcription factor KLF2 is associated with the dysfunctional status of NK cells and the prognosis of pediatric B-ALL patients
by: Fang Wu, et al.
Published: (2025-01-01)

Homozygous CDKN2A/B deletions in low- and high-grade glioma: a meta-analysis of individual patient data and predictive values of p16 immunohistochemistry testing
by: Darius Noack, et al.
Published: (2024-11-01)

Diagnostic utility of LMO2 immunohistochemistry in distinguishing T-lymphoblastic leukemia/lymphoma from thymoma
by: Divya Bansal, et al.
Published: (2023-01-01)

A comprehensive prognostic and immune analysis of LAPTM4B in pan-cancer and Philadelphia chromosome-positive acute lymphoblastic leukemia
by: Hui Zhou, et al.
Published: (2025-02-01)

Cdkn1a silencing restores myoblast differentiation by inducing selective apoptosis in senescent cells
by: Sujin Kim, et al.
Published: (2025-04-01)

Changes in the Outcome of Pediatric Patients with Acute Lymphoblastic Leukemia—Single Center, Real-Life Experience
by: Letitia E. Radu, et al.
Published: (2025-06-01)

Case Report: FGFR2 inhibitor resistance via PIK3CA and CDKN2A/B in an intrahepatic cholangiocarcinoma patient with FGFR2-SH3GLB1 fusion
by: Nadja Ballin, et al.
Published: (2025-04-01)

Hereditary oral squamous cell carcinoma associated with CDKN2A germline mutation: a case report
by: Ah-Reum Jeong, et al.
Published: (2022-02-01)

Cytogenetic finding of simultaneous inversion of chromosome 14 and tetrasomy 8 in a Pediatric B-Lymphoblastic Leukemia-a case report
by: Kiran Sachwani, et al.
Published: (2025-07-01)

Decoding the diagnostic biomarkers of mitochondrial dysfunction related gene variants in pediatric T cell acute lymphoblastic leukemia
by: Yunfeng Lu, et al.
Published: (2025-07-01)

LINC01094 promotes gastric cancer through dual targeting of CDKN1A by directly binding RBMS2 and HDAC1
by: Xinyi Zhou, et al.
Published: (2024-12-01)

Retinoic acid inhibition of cell proliferation via activation of CDKN1B signaling in the forebrain and spinal cord during mouse embryonic development
by: Ahmed Said, et al.
Published: (2024-11-01)

Prognostic factors of children’s acute lymphoblastic leukemia therapy in Moscow—Berlin protocols
by: J. V. Roumiantseva, et al.
Published: (2022-11-01)

Chemotherapy‐Induced Peripheral Polyneuropathy in Pediatric Acute Lymphoblastic Leukemia: A Case Report on Manifestation, Management, and Outcome
by: Eman Al Mattar, et al.
Published: (2025-08-01)

Changes in thyroid hormone status following induction chemotherapy in patients with pediatric acute lymphoblastic leukemia
by: Jingzi Zhong, et al.
Published: (2025-07-01)

5q deletion in childhood T-acute lymphoblastic leukemia at diagnosis: a case report
by: Yousra Sbibih, et al.
Published: (2025-06-01)

Loss of Cdkn1a protects against MASLD alone or with alcohol intake by preserving lipid homeostasis
by: Arantza Lamas-Paz, et al.
Published: (2025-01-01)